Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Bone Loss, Perimenopausal

pyrrolidine dithiocarbamate has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dillehay, DL; Li, Y; Strait, K; Weitzmann, MN	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Bone Loss, Perimenopausal

Article	Year
Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency. International journal of molecular medicine, 2008, Volume: 21, Issue:4 Topics: Animals; Bone Resorption; Collagen Type I; Estrogens; Female; Humans; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoporosis, Postmenopausal; Ovariectomy; Peptides; Pyrrolidines; Radiographic Image Interpretation, Computer-Assisted; Signal Transduction; Thiocarbamates; Tomography, X-Ray Computed	2008

Article

Year

Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.

International journal of molecular medicine, 2008, Volume: 21, Issue:4

Topics: Animals; Bone Resorption; Collagen Type I; Estrogens; Female; Humans; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoporosis, Postmenopausal; Ovariectomy; Peptides; Pyrrolidines; Radiographic Image Interpretation, Computer-Assisted; Signal Transduction; Thiocarbamates; Tomography, X-Ray Computed

2008